The increased prevalence of HαT among individuals with SM has been proposed to result from the distinct properties of α/β-tryptase heterotetramers, and the prevalence of any α-tryptase-containing allele has been reported to be significantly increased among individuals with SM [11,33,34]. The gene discussed is TMPRSS11D; the disease is systemic mastocytosis.